| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Dec―20 |
Attitude of Previous Blood Donors toward Blood Donation during COVID-19 |
Hatem M. Alahwal, Yasmin Mohamed Abbas Nour, Shahida A. Khan, Ahmed S Barefah, Salem M. Bahashwan, Osman O. Radhwi, et al. (+5) Atheer Mousa Saeed Alzahrani, Rawan Azizullah Marouf Tash, Weam M Bajunaid, Afaf Bader Radi Alkhaldi, Abdullah T. Almohammadi |
| 2 |
[GO] |
2023―Dec―20 |
D-dimer and Ferritin Levels in Prediction of COVID-19 Severity |
Hujaz Ismail Abdulrazzaq Alqirbi, Wafaa Hazim Salih, Batool Mutar Mahdi |
| 3 |
[GO] |
2023―Dec―20 |
Clinical Presentation, Management, and Outcomes of Coronavirus Disease 2019 Infection in Children on Active Therapy for Cancer and Posthematopoietic Stem Cell Transplantation: Experience from a Tertiary Care Center |
Mohammed Kamal, Wasil Jastaniah, Ibraheem Abosoudah, Mohammed Bayoumy, M. Nawaf Aldajani, Mona Bahasan, et al. (+3) Amal Alseraihy, Tahani Elfadul, Hassan Al-Trabolsi |
| 4 |
[GO] |
2023―Dec―20 |
The Comparison of Soluble P-selectin, Anti-platelet Factor 4, and Platelet Maximum Aggregation Levels among Coronavirus Disease 2019 Patients |
Andhika Rachman, Rahmanu Reztaputra, Adityo Susilo, Pringgodigdo Nugroho, Rachelle Betsy, Samuel Juanputra |
| 5 |
[GO] |
2023―Sep―26 |
Role of coagulation parameters and inflammatory biomarkers in coronavirus disease 2019 patients: A demystifying endeavor |
BN Kumarguru, Sindhu Sreegiri, D Swathi, AS Ramaswamy, CA Arathi |
| 6 |
[GO] |
2023―Feb―17 |
Morphological Changes in Blood Cells as Indicators for Disease Progression in COVID-19 |
AAbinaya Sundari, R Shivapriya, TM Karthikeyan, Veenaa Venkatesh |
| 7 |
[GO] |
2023―Feb―17 |
Impact of COVID-19 Pandemic on Treatment Decisions of Patients Treated by Hematologists in Saudi Arabia |
AhmedS Barefah, SalemM Bahashwan, HatemM Alahwal, AbdullahT Almohammadi, OsmanO Radhwi, ShahidaA Khan |
| 8 |
[GO] |
2023―Feb―17 |
Outcome of Haploidentical Hematopoietic Stem Cell Transplantation with a Donor and Recipient Infected with SARS-CoV-2 Infection |
GadAllah Ali, Majed Altareb, Naeem Chaudhri, FerasAbdulaziz Alfraih |
| 9 |
[GO] |
2022―Oct―18 |
Von willebrand factor level and activity in correlation with D-dimer level among COVID-19 patients in Saudi Arabia |
RehabYusuf Al-Ansari, FatimahSalim AL-Yami, LamiaaHamad Al-Jamea, LeenaMohamed Osman Abdalla, AbdulrahmanHassan Halawi, AbdullahMohammed AlShehri, et al. (+3) Nawaf Zakary, ArulananthamZechariah Jebakumar, Alexander Woodman |
| 10 |
[GO] |
2022―Oct―18 |
Anticoagulant status under COVID-19: The potential pathophysiological mechanism |
BasheerAbdullah Marzoog |
| 11 |
[GO] |
2022―Oct―18 |
Quality of systematic reviews/meta-analyses in coronavirus disease 2019 and venous thromboembolism: An analysis using a measurement tool to assess systematic reviews-2 |
Osman Radhwi, Sultan Alkhamesi, Abdullah Almohammadi, Hatem Alahwal, Ahmed Barefah, Salem Bahashwan |
| 12 |
[GO] |
2022―Sep―15 |
Cold agglutinin disease in COVID-19 causing severe intravascular hemolysis |
SarahGrace Priyadarshini, Sreelakshmi Pasupulati |
| 13 |
[GO] |
2022―Jan―18 |
Hemophagocytic lymphohistiocytosis trigged by COVID-19 infection: Case report and review of the literature |
Fatma Hammami, Makram Koubaa, Khaoula Rekik, Hana Chaabouni, Mourad Chaari, Fatma Smaoui, MounirBen Jemaa |
| 14 |
[GO] |
2022―Jan―18 |
Platelets derived microparticles in COVID-19: Correlation to inflammatory and coagulation State |
MervatAbdalhameed Alfeky, MariamFathy Abdelmaksoud, SaharSamir Abdelmaksoud, HanaaFathy Abdelsamee, HiebaGamal Ezzelregal |
| 15 |
[GO] |
2021―Aug―06 |
A review of the pathological mechanisms and clinical implications of coagulopathy in COVID-19 |
Suvir Singh, Kunal Jain, Davinder Paul, Jagdeep Singh |
| 16 |
[GO] |
2021―Aug―06 |
Effect of COVID-19 pandemic on oncology services and the impact of specific measures in reducing the delays |
Khalid AlSaleh |
| 17 |
[GO] |
2021―Aug―06 |
COVID-19 vaccines and their potential use in patients with hematological malignancies |
Ashraf Dada, Ghadeer Al-Bishi, Binyam Usman |
| 18 |
[GO] |
2020―Jul―27 |
Management of hematological malignancies during the COVID-19 pandemic |
Aamer Aleem, Mashael Altowairqi, Yazeed Bajuaifer, Musa Alzahrani |
| 19 |
[GO] |
2020―Jul―27 |
Sickle cell disease: High risk or no risk for coronavirus disease 2019 infection |
MuneerHassan Albagshi, MahmoudH Albagshi |
| 20 |
[GO] |
2020―Jul―27 |
Hematologists' adaptations and contingency plans to the coronavirus disease-2019 crisis |
Riad El Fakih |
